معرفی
Shafiq Ahmed is a researcher at Newcastle University specializing in medicinal chemistry and cancer therapeutics, with a focus on disrupting the MDM2-p53 protein-protein interaction—a critical target in oncology. His work bridges biochemical mechanisms and drug development for tumor suppression pathways.
His core research domains include:
- Biochemistry (protein interactions and signaling pathways)
- Medicinal Chemistry (small-molecule inhibitor design)
- Cancer Research (p53 tumor suppressor mechanisms)
- Drug Discovery (scaffold optimization and potency enhancement)
Analysis of his publications reveals a methodical progression from foundational scaffold development (2005) to advanced structure-activity optimization (2011), emphasizing isoindolinone-based compounds as promising anticancer agents. His contributions center on improving binding affinity and specificity for MDM2-p53 inhibition, with implications for targeted cancer therapies.
No scientific awards, student supervision records, or laboratory affiliations were documented in the source material.
حوزههای پژوهشی